BAP Pharma is a global leader in clinical trials supply, specializing in comparator sourcing, secondary packaging, and medicines access. Founded in 2010, it offers responsive and cost-effective clinical trial supplies and medicines access solutions. The company sources, supplies, and distributes high-quality comparators, develops and produces clinical secondary packaging and labeling, and provides custom access solutions to healthcare professionals and patients globally. With a focus on solution-oriented approaches, BAP Pharma's strengths lie in its clear and continuous communication, proven project management models, and international distribution and storage capabilities. The company's unrivaled ability to supply comparators and co-medications globally, coupled with its in-house market assessments, enables cost-effective and flexible solutions from a robust supply chain. Additionally, its expertise in Early and Managed Access Programs allows it to source pre/post-approval, orphan, and niche medicines, ensuring access and continuity of treatment for patients worldwide. BAP Pharma also offers ongoing consultation and support in regulatory affairs, quality assurance, documentation, submissions, and reimbursement, leveraging its market insights, detailed supply chain knowledge, requisite country licenses, regulatory expertise, and global network to address medicine shortages and supply unmet demand in countries. The company operates within the Biotechnology, Health Care, Logistics, Manufacturing, and Pharmaceutical industries.
There is no investment information
No recent news or press coverage available for BAP Pharma.